PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
54.58
ESG score below 80% of INKT's 68.97. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
49.62
Environmental score 80-90% of INKT's 59.45. Walter Schloss would scrutinize carbon exposure and transition planning.
57.51
Social score below 80% of INKT's 76.83. Jim Chanos would check for potential social license and litigation risks.
56.60
Governance score 80-90% of INKT's 70.64. Walter Schloss would scrutinize management accountability and board independence.